Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-20-020118)

Filing Details

Accession Number:: 0001127602-20-020118
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-06-19 19:24:17
Reporting Period:: 2020-06-18

Accepted Time:: 2020-06-19 19:24:17
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1682852	Moderna Inc.	MRNA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1221127	M. Lori Henderson	C/O Moderna, Inc. 200 Technology Square Cambridge MA 02139	General Counsel And Secretary	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-06-18	64,000	$14.85	64,681	No	4	M	Direct
Common Stock	Disposition	2020-06-18	64,000	$63.03	681	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2020-06-18	64,000	$0.00	64,000	$14.85

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
399,522		2028-06-26	No	4	M	Direct

Footnotes

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 6, 2020.
Includes 681 shares acquired under the Moderna, Inc. 2018 Employee Stock Purchase Plan on May 29, 2020.
25% of this option will vest and become exercisable on April 9, 2019 with the remainder vesting in 12 equal quarterly installments thereafter.